RxDoctor Payments Data

Allison Hutcherson, PA

Medical · San Antonio, TXNPI 1104208883

Payments from drug & device makers

$1,000in general payments, 2019–2025

Across 53 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$256
  • Viiv Healthcare Company$250
  • Gilead$111
  • Shionogi Inc$49
  • Insmed, Inc.$46
  • Octapharma USA, Inc.$40
  • plus $248 from 10 others

What the payments were for

  • Speaking & faculty fees$131%
  • Food & beverage$98799%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,000 in reported general payments places this provider in the 55th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$1,780,456
Medicare patients
443
Services billed
33,457

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala101$395,800
GenvoyaElviteg/Cob/Emtri/Tenof Alafen26$98,818
TivicayDolutegravir Sodium14$55,683
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf12$53,043
DescovyEmtricitabine/Tenofov Alafenam25$52,539
PrezcobixDarunavir/Cobicistat13$32,165
Daptomycin68$23,713
ErtapenemErtapenem Sodium49$14,684
Doxycycline Hyclate331$9,700
Cefpodoxime Proxetil37$7,381
Meropenem60$6,806
Cefdinir130$6,352
CeftriaxoneCeftriaxone Sodium72$5,535
Vancomycin Hcl48$5,241
Cefepime Hcl36$4,292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy$111$547,157152 claims
Viiv Healthcare CompanyTivicay$250$55,68314 claims
Johnson & JohnsonPrezcobix$13$32,16513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,490 medical providers in Texas.

Other medical in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →